Pazopanib HCL intermediates manufacturer

Pazopanib HCL intermediates
Tel: +86-311-67591193 sales@dingminpharma.com
News
Your location: Home » News > Company news

decitabine mechanism of action

Product Description

Product Name: Decitabine
Specification: 99.51%
CAS No.: 2353-33-5
Standard: USP
Function: Antineoplastic Agents, Anti-cancer

Product name Decitabine MFG. Date 20130111
Package 1kg/bag Batch number FH20130111
Testing Date 20130111 Exp Date 20150111
Standard USP32 Quantity 10Kg
Cas No. 2353-33-5 Odor Characteristic
Molecular Formula C8H12N4O4 Molecular Weight 228.20
Function Main functions are as follows:
Antineoplastic Agents, Anti-cancer 
Applications Main applications are as follows:
Anticancer chemotherapy
Items Tested Specification Result
Characters White to off-white crystalline powder Confirms
Melting Point 198-203 Degree  Confirms
UV-Absorbance +74°—+80°(in methanol 10mg/ml) +67.5°
Assay (HPLC) ≥99.00%  99.51%
Loss on Drying Not more than1.0% 0.21%
Related substances Not more than 1.0% 0.11%
The largest impurities ≤0.3% 0.09%
Total impurities(HPLC) ≤1.0% 0.43%
Total aerobic microbial ≤100cfu/g 59cfu/g
Heavy Metal ≤10ppm conforms
Staphylococcus aureus Absence Absence
Pseudomonas aeruginosa Absence Absence
Salmonella species Absence Absence
Escherichia Absence Absence
Conclusion Conforms USP32  
Decitabine

Other Article
PRODUCTS LIST
CONTACT US
Office Address: No.41, Zhaiying South Street, Yuhua District, Shijiazhuang, Hebei Province.China
R&D and Plant Address: JingShi Cooperative Innovation Industrial Park,No.769 Taihang Street,High-tech Zone,Shijiazhuang
Tel: +86-311-67591193
Fax: +86-311-67591193
sales@dingminpharma.com
Online Service×